
The main therapeutic areas in which we are working are:
Adacyte Therapeutics is a pioneering company committed to the development and commercialization of unique and innovative therapeutic solutions for the treatment of complex diseases.
Our genuine interest in patients voice inspires our vision to continue globally developing GMA (Granulocyte-Monocyte Apheresis) as an effective and safe treatment option for IBD and other autoimmune diseases. GMA is today a growing and emerging medical technology which offers a therapeutic alternative to the standard treatments.
Antoni Villaró. Founder & CEO
Copyright 2020 © Adacyte Therapeutics | C/ Jesús Serra Santamans, 5, 08174 Sant Cugat del Vallès (Barcelona)
Legal Advice | Privacy Policy | Social Network Privacy Policy | Cookies Policy | EN-COR-0320001